← Back to headlines
Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion in Psychedelic Foray
Eli Lilly is set to acquire AtaiBeckley for a sum of up to $3.8 billion, marking the latest venture by a major pharmaceutical company into the psychedelic drug market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Fishwife CEO Hires Candidate Based on Cold LinkedIn Outreach
28m ago
QuickFlips Founder Turns Side Hustle into $4 Million Video Game Resale Business
31m ago
DoorDash Pays Gig Workers to Load Delivery Robots, Highlighting Automation Shortcoming
31m ago
Cheryl Patella Moves from Miami to Rural North Florida for Improved Lifestyle
45m ago